Trump's FDA chief takes wide aim at opioid addiction crisis

Washington

THE Food and Drug Administration (FDA) plans to look into making some unusual allies in order to limit the consumption of opioid painkillers - health insurers and companies that manage prescription-drug benefits.

FDA commissioner Scott Gottlieb, who is mounting a sweeping overhaul of the regulation of these addictive pills, plans to meet the benefit payers and insurance administrators in September; these are groups that the FDA has not typically worked with in its role as a drug regulator.